What supplements are recommended for treating neuropathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Supplements for Neuropathy

Vitamin B supplementation can be discussed for chemotherapy-induced neuropathy, but there is insufficient evidence to routinely recommend vitamin supplements for diabetic neuropathy, with the exception of documented B12 deficiency in metformin users. 1, 2

Evidence-Based Supplement Recommendations

Vitamin B12: Limited Role, Test Before Treating

  • Test vitamin B12 levels in patients taking metformin, particularly those with anemia or peripheral neuropathy, and supplement only when deficiency is documented 2
  • Vitamin B12 supplementation can be discussed for chemotherapy-induced peripheral neuropathy as supportive care 1
  • Oral vitamin B12 supplementation shows no consistent evidence of improving clinical symptoms or electrophysiological markers in diabetic neuropathy when deficiency is not present 3
  • However, recent meta-analysis data suggests B12 may reduce neuropathic symptoms and pain scores in diabetic neuropathy patients, though the quality of evidence remains limited 4
  • Do not routinely supplement B12 without documented deficiency, as per American Diabetes Association guidelines 2

Alpha-Lipoic Acid: Consider as Adjunctive Therapy

  • Alpha-lipoic acid 600 mg orally once daily may be considered as adjunctive therapy for symptomatic diabetic polyneuropathy 1, 2, 5
  • ALA is not FDA-approved in the United States but has growing evidence from diabetic neuropathy studies 1, 2
  • Should be used in addition to, not instead of, standard pain management with gabapentinoids, SNRIs, or tricyclic antidepressants 2, 5

Vitamin D: Insufficient Evidence

  • There is insufficient evidence to support routine vitamin D supplementation for improving glycemic control or neuropathy 2
  • Use should be guided by national guidelines for those at risk of deficiency or insufficient intake, not for neuropathy treatment specifically 2

Supplements to AVOID: No Evidence of Benefit

  • Do not recommend antioxidants (vitamins E, C, or carotene) due to lack of efficacy evidence and concern for long-term safety 1, 2, 5
  • Do not recommend herbal supplements (cinnamon, curcumin, aloe vera), chromium, or omega-3 fatty acid supplements due to insufficient evidence 2, 5
  • Vitamin E deficiency can cause peripheral neuropathy and requires treatment with 100-400 IU daily, but supplementation in non-deficient patients is not recommended 1
  • Vitamin B6 deficiency causes peripheral neuropathy with motor dysfunction, but routine supplementation without documented deficiency is not supported 1

First-Line Treatment: Not Supplements

Optimize Disease Control First

  • Achieve near-normal glycemic control as the only intervention proven to prevent or delay neuropathy development in type 1 diabetes and slow progression in type 2 diabetes 1, 2, 5
  • Optimize blood pressure control, which decreased cardiovascular autonomic neuropathy risk by 25% in the ACCORD trial 1, 2, 5
  • Optimize lipid control, as dyslipidemia is a key factor in neuropathy development 1, 2, 5
  • Promote physical activity and weight loss, which show positive effects on diabetic peripheral neuropathy 1, 2, 5

Evidence-Based Pharmacologic Pain Management

  • Gabapentinoids (pregabalin 100 mg three times daily or gabapentin titrated to 2400 mg/day in divided doses) are first-line pharmacologic treatments for neuropathic pain 1, 2, 5, 6
  • Serotonin-norepinephrine reuptake inhibitors (duloxetine 60-120 mg daily) are FDA-approved and recommended as first-line therapy 1, 2, 5
  • Tricyclic antidepressants (amitriptyline 10-75 mg at bedtime or nortriptyline 25-75 mg at bedtime) are also first-line options 1, 2, 5
  • Topical capsaicin 8% dermal patch (single 30-minute application) provides pain relief for at least 12 weeks in HIV-associated neuropathy 1

Special Populations and Contexts

Chemotherapy-Induced Peripheral Neuropathy

  • Vitamin B supplementation can be discussed as supportive care, though evidence is limited 1
  • Physiotherapy, physical activity, referral to podiatrists, patient education on adequate footwear, and acupuncture can be helpful 1
  • If neuropathy induces chronic pain, gabapentin or venlafaxine may be introduced, though efficacy is usually limited 1

HIV-Associated Neuropathy

  • Gabapentin is strongly recommended, with typical adult regimen titrating to 2400 mg per day in divided doses 1
  • Alpha-lipoic acid is recommended for HIV-associated peripheral neuropathic pain, though studies in HIV patients are lacking 1
  • Medical cannabis may be effective in appropriate patients, particularly those with prior cannabis use, but balance benefits against neuropsychiatric adverse effects and addiction risk 1
  • Do not use lamotrigine, as it does not relieve HIV-associated neuropathic pain 1

Immune Checkpoint Inhibitor-Related Neuropathy

  • For Grade 2 neuropathy, use nonopioid management of neuropathic pain with pregabalin, gabapentin, or duloxetine 1
  • Workup should include testing for reversible causes: HbA1c, vitamin B12, TSH, vitamin B6, folate 1

Critical Pitfalls to Avoid

  • Do not recommend supplements as substitutes for proper glycemic control and evidence-based medications 2, 5
  • Do not assume "natural" supplements are harmless—antioxidants have long-term safety concerns 2, 5
  • Do not use opioids as first-line agents for chronic neuropathic pain due to addiction risk, cognitive impairment, and lack of long-term efficacy 1, 5
  • Start medications at low doses and titrate slowly, especially in older patients, to minimize side effects 5
  • Refer to neurology or pain specialist when pain control is not achieved within your scope of practice 1, 2, 5
  • Do not delay testing for B12 deficiency in metformin users presenting with neuropathy symptoms 2, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Diabetic Neuropathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diabetic Radiculopathy Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.